Albert H. Gennip
- Molecular Biology top 1%
- Oncology top 1%
- Clinical Biochemistry top 0.5%
- Infectious Diseases top 2%
- Epidemiology top 5%
- Co-authors
- André B. P. KuilenburgStephan KempHuib N. CaronRutger MeinsmaP. VrekenHenk van LentheDirk de KorteLida Zoetekouw
- Topics
- Biochemical and Molecular Research (71 papers)Metabolism and Genetic Disorders (33 papers)Neonatal Health and Biochemistry (23 papers)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Albert H. Gennip
133 papers receiving 6.6k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Molecular Biology 4.8k
- Oncology 1.7k
- Clinical Biochemistry 758
- Infectious Diseases 673
- Epidemiology 615
Countries citing papers authored by Albert H. Gennip
This map shows the geographic impact of Albert H. Gennip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert H. Gennip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert H. Gennip more than expected).
Fields of papers citing papers by Albert H. Gennip
This network shows the impact of papers produced by Albert H. Gennip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert H. Gennip. The network helps show where Albert H. Gennip may publish in the future.
Co-authorship network of co-authors of Albert H. Gennip
This figure shows the co-authorship network connecting the top 25 collaborators of Albert H. Gennip. A scholar is included among the top collaborators of Albert H. Gennip based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert H. Gennip. Albert H. Gennip is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 21 | |
| 3 | 123 | |
| 4 | 49 | |
| 5 | 78 | |
| 6 | 3 | |
| 7 | 23 | |
| 8 | 17 | |
| 9 | Severe 5-fluorouracil toxicity caused by reduced dihydropyrimidine dehydrogenase activity due to heterozygosity for a G -> A point mutation (vol 21, pg 280, 1998) | 1 |
| 10 | 21 | |
| 11 | 24 | |
| 12 | 5 | |
| 13 | 4 | |
| 14 | 5 | |
| 15 | 90 | |
| 16 | 6 | |
| 17 | 3 | |
| 18 | 6 | |
| 19 | 58 | |
| 20 | 1 |
About Albert H. Gennip
Albert H. Gennip is a scholar working on Clinical Biochemistry, Molecular Biology and Pediatrics, Perinatology and Child Health, having authored 135 papers that have together received 6.7k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (71 papers), Metabolism and Genetic Disorders (33 papers) and Neonatal Health and Biochemistry (23 papers). The work is most often cited by research in Clinical Biochemistry (758 citations), Virology (367 citations) and Molecular Biology (4.8k citations). Albert H. Gennip has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include André B. P. Kuilenburg, Stephan Kemp, Huib N. Caron, Rutger Meinsma, P. Vreken, Henk van Lenthe, Dirk de Korte, Lida Zoetekouw, N. G. G. M. Abeling and Ronald J. A. Wanders. Their work appears in journals such as Journal of Clinical Oncology, The EMBO Journal and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.